Name | 4-amino-8-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-oxopyrido[2,3-d]pyrimidine-6-carboxamide |
---|---|
Synonyms | NSC 177223 |
Description | API-1, a potent Akt/PKB inhibitor, binds to the PH domain and inhibits Akt membrane translocation. API-1 efficiently reduces the phosphorylation levels of Akt with an IC50 of ∼0.8 μM. API-1 is selective for PKB and does not inhibit the activation of PKC, and PKA. API-1 also induces apoptosis by synergizing with TNF-related apoptosis-inducing ligand (TRAIL)[1][2]. |
---|---|
Related Catalog | |
References |
Density | 1.792g/cm3 |
---|---|
Boiling Point | 795.8ºC at 760 mmHg |
Molecular Formula | C13H15N5O6 |
Molecular Weight | 337.28800 |
Flash Point | 435.1ºC |
Exact Mass | 337.10200 |
PSA | 186.81000 |
Index of Refraction | 1.764 |
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H301 |
Precautionary Statements | P301 + P310 + P330 |
RIDADR | UN 2811 6.1 / PGIII |
~28% 36707-00-3 |
Literature: LYNDOR BIOSCIENCES L.L.C.; AKINSANMI, Lawrence; KINCAID, John Patent: WO2012/158197 A2, 2012 ; Location in patent: Page/Page column 107 ; |
~% 36707-00-3 |
Literature: LYNDOR BIOSCIENCES L.L.C.; AKINSANMI, Lawrence; KINCAID, John Patent: WO2012/158197 A2, 2012 ; |
~% 36707-00-3 |
Literature: LYNDOR BIOSCIENCES L.L.C.; AKINSANMI, Lawrence; KINCAID, John Patent: WO2012/158197 A2, 2012 ; |
Precursor 3 | |
---|---|
DownStream 0 |